Targeted Therapy for Laryngeal Cancer

Laryngeal cancer affects the voice box, vital for speaking and breathing. It occurs when abnormal cells grow uncontrollably in the larynx, leading to the formation of tumours. Smoking, excessive alcohol intake and exposure to certain chemicals increase the risk of developing this type of cancer. Read till the end to learn more about laryngeal cancer and treatment options in this field from a leading head and neck cancer doctor in Kolkata. 

Traditional Treatments and Their Limitations

Traditionally, treatments for laryngeal cancer include surgery, radiation therapy and chemotherapy. While these methods can be effective, they may also cause side effects such as difficulty swallowing, voice changes and damage to nearby tissues.

Targeted Therapy: A Promising Approach

Targeted therapy is a newer treatment option for laryngeal cancer. The top cancer doctor in Kolkata uses it to attack specific abnormalities within cancer cells while minimizing damage to healthy cells. Unlike chemotherapy, which affects all rapidly dividing cells, targeted therapy specifically targets molecules involved in the growth and spread of cancer cells.

How does Targeted Therapy Work?

Targeted therapy drugs work by interfering with specific molecules that play a role in cancer growth. For example, some drugs block the action of proteins that promote cancer cell division, while others inhibit the formation of blood vessels that supply nutrients to tumours. By targeting these specific molecular pathways, targeted therapy can help slow down or stop the growth of cancer cells.

Benefits of Targeted Therapy

One of the main advantages of targeted therapy is its ability to target cancer cells more precisely, potentially leading to fewer side effects than traditional treatments. Additionally, targeted therapy may be effective for some patients who do not respond well to other treatments or who have advanced or recurrent laryngeal cancer.

Targeted therapy administered by an expert head and neck cancer doctor in Kolkata offers a promising approach for the treatment of laryngeal cancer by explicitly targeting the molecular abnormalities driving cancer growth. With ongoing research and development, targeted therapy can potentially improve outcomes and quality of life for patients with this disease.